Antiviral and Related Nucleoside Drugs

Antiviral and Related Nucleoside Drugs

Antiviral and Related Nucleoside Drugs The current outbreak of the novel coronavirus 2019-nCoV, a single-stranded positive-sense RNA (+ssRNA) virus, urges researchers to explore more efficient antiviral drugs. Granlen has almost 60 antiviral nucleoside drugs that could be the candidates in this arena. Hundreds of the closely related analogues are in stock for immediate biological tests and SAR studies. Our teams are ready to make further derivatives to support. NH2 GL100199 N CAS#123402-20-0 HO N O Antiviral agent O 3’-Deoxy-3’-fluorocytidine F OH O GL100612 N NH HO N N NH CAS#123402-21-1 O 2 Antiviral agent 3’-Deoxy-3’-fluoroguanosine F OH O I GL100224; CAS#69123-98-4 NH HO N O 5-Iodo-2’-deoxy-2’-fluoro-beta-D- O HBV drug, Fialuridine arabinouridine FIAU F HO GL100222, CAS#69123-94-0 O NH FAU, antiviral and anticancer 2’-Deoxy-2’-fluoro--D-arabinouridine, 2’- HO N O O F agent Fluoro-2’-deoxyuracyl--D-arabinofuranoside HO O H3C GL100900 NH HO N O CAS#69256-17-3; 2’-Deoxy-2’-fluoro-5- O HBV drug Clevudine methyl-beta-D-arabinouridine; FMAU F HO NH2 I GL100674 N antiviral drug, Fiacitabine; anti- HO N O CAS#69123-90-6; 5-Iodo-2’-deoxy-2’-fluoro- O infective therapy; antitumor beta-D-arabinocytidine, FICA F agent HO NH2 GL102999 N HO N O CAS#1011529-10-4 O Antiviral drug Azvudine F N3 4’-Azido-2’-deoxy-2’-fluoroaracytidine HO NH2 GL100575 N N antiviral agent; Protozoan parasite HO N N CAS#20227-41-2 O T. vaginalis inhibitor; Antisense 2’-Deoxy-2’-fluoroarabinoadenosine, 2’F-araA F target RNase HO O GL100617 NH HO N O CAS#31448-54-1 O Antiviral agent (TBEV) CH3 2’--C-Methyl uridine OH OH NH2 GL100619 N Antiviral agent; HCV drug HO N O CAS#20724-73-6 O CH3 NM107 2’-C-Methyl cytidine OH OH O GL102998 NH HO N O CAS#863329-66-2 O antiviral agent CH3 (2’R)-2’-Deoxy-2’-fluoro-2’-methyluridine HO F O O NH GL103019 O O HN P O N O CAS#1190307-88-0 O O HCV drug CH3 Sofosbuvir HO F NH2 GL100687 N N HCV and antiviral agent, RdRp HO N N CAS#15397-12-3 O CH3 inhibitor 2’--C-Methyladenosine HO OH 1 NH2 GL100640 N HO HCV replication inhibitor; N N CAS#443642-29-3 O CH3 antiviral agent 2’-beta-C-methyl tubercidin; MRK608 HO OH O GL100898 N NH HO N N CAS#374750-30-8 O NH2 Antiviral agent, HCV inhibitor 2’-C-beta-Methylguanosine CH3 HO OH O GL100823 NH HO N O CAS#215176-58-2 O Antiviral agent 3’-Azido-3’-deoxy-5-methyuridine N3 OH GL101276 NH2 N Ribonucleotide reductase CAS#51034-68-5 HO N O O inhibitor; antiviral agent 2’-Azido-2’-deoxycytidine HO N 3 NH2 GL100826 N N HO N N CAS#58699-62-0 O Antiviral antineoplastic agent 3’-Azido-3’-deoxyadenosine N3 OH O H C GL101268 3 NH HO N O CAS#108630-07-5 O Anticancer antiviral agent 3’-Amino-3’-deoxy-5-methyluridine H N OH 2 NH2 GL100226 N Balpiravir, HCV RdRp NS5B HO N O CAS#478182-28-4 O polymerase inhibitor, treat N3 4’-alpha-Azido-cytidine, R-1479 HO dengue virus infection OH H3C NH GL100909 O- N N+ HO CAS#113509-54-9 N N Antiviral agent O N6-Methyladenosine N1-oxide HO OH NH2 O- GL101125 N + N Antiviral and anti-inflammatory HO N N CAS#146-92-9 O 1 agent Adenosine N -Oxide HO OH GL102080 antiviral and immunosuppressive CAS#605-23-2 agents Arabinofuranosyl thymine NH2 GL101177 N N HO N N CAS#5536-17-4; Ara-adenosine O Antiviral Drug, Vidarabine 9-(-D-Arabinofuranosyl)adenine OH HO NC NH2 GL101581; CAS#606-58-6; Toyocamycin N antitumor antiviral antibiotics, HO N N 4-Amino-5-cyano-7-(-D-ribofuranosyl)-7H- O IRE1a inhibitor, PI3 kinase pyrrolo[2.3-d]pyrimidine inhibitor HO OH O NH2 GL101582; CAS#18417-89-5; Sangivamycin H2N N protein kinase inhibitor, antiviral HO 4-Amino-7-(-D-ribofuranosyl)-7H- N N O antimalarial agent pyrrolo[2.3-d]-pyrimidine-5-carboxamide HO OH O GL100970 NH HO N N CAS# 62160-23-0 O NH2 Antiviral agent, anti-HCV 7-Deazaguanosine OH HO HN GL100318 O N N HO CAS#4338-47-0 N N Anticancer and antiviral agent O N6-Furfuryladenosine HO OH 2 GL102055 HN N N antiviral agent, natural cytokinin CAS#4294-16-0 HO N N O nucleoside N6-Benzyladenosine HO OH GL102581 NH N N antiviral agent; plant cytokinin HO CAS#7724-76-7 N N O nucleoside N6-Isopentenyladenosine HO OH CF3 GL103080 HN N N Antiviral agent, cytokinin HO CAS#23661-03-2 N N O nucleoside N6-(3-Trifluoromethylbenzyl)adenosine HO OH HN GL103081 N N CF3 Antiviral agent, cytokinin HO N N CAS#722505-71-7 O 6 nucleoside N -(4-Trifluoromethylbenzyl)adenosine HO OH GL100209 natural antibiotics, antifungal CAS#14675-48-0; antiviral agent 6-Methylpurine-9-beta-D-riboside, 6-D-MPR O H N GL102583 2 NH CAS#2149-76-0 HO N O Anticancer antiviral agent O 5-Aminouridine HO OH O H CO GL100725 3 NH P2Y6 receptor agonist; RNA HO N O CAS#35542-01-9 O anticodon nucleoside for mRNA 5-Methoxyuridine vaccines OH OH O GL102027; CAS#36791-04-5 N NH2 HO N N 1--D-ribafuranosyl-1H-1,2,4-triazole-3- O HCV drug Ribavirin carboxamide OH OH NH2 GL101309 N HO N O CAS#7057-33-2 O Antiviral agent 3’-Deoxycytidine OH O GL102981 NH antiviral drug, Herpies simplex CAS#15176-29-1; 5-Ethyl-2’-deoxyuridine; HO N O O virus; DNA polymerase inhibitor Edoxudine (EUDR) HO O GL101962 HN OH CAS#5116-24-5 HO O N Antiviral and anticancer agent O 5-Hydroxymethyl-2’-deoxyuridine OH O I GL100246 NH N CAS#54-42-2 O O antiviral agent Idoxuridine, IDU HO 5-Iodo-2’-deoxyuridine HO O I GL100185; CAS#55612-21-0 NH HO N O 2’-Deoxy-2’-fluoro-5-iodouridine O antiviral agent 2’-epi-Fialuridine OH F O GL101122 NH HO N O CAS#41107-56-6 O Anti-HIV agent 2’,3’-Dideoxy-3’-fluorouridine, FddU F O GL101365 NH antiviral drug Alovudine, DNA CAS#25526-93-6 HO N O polymerase inhibitor, HIV-I O 3’-Deoxy-3’-fluoro-thymidine inhibitor F 3 O Cl GL101124 NH CAS#119644-22-3 HO N O Raluridine, HIV-1 inhibitor O 5-Chloro-2’,3’-dideoxy-3’-fluorouridine F NH2 GL101181 N CAS#51246-79-8 HO N O HIV inhibitor O 2’,3’-Dideoxy-3’-fluorocytidine; FddC F NH2 GL102596 N N HO N N CAS#87418-35-7 O anti-HIV agent 2’,3’-Dideoxy-3’-fluoroadenosine, 3’-F-ddA F O GL101956 NH HO N O CAS#84472-85-5 O HIV drug AZDU, AzddU 3’-Azido-2’,3’-dideoxyuridine; 3’-Azido-ddU N3 O GL101973 NH HIV drug Zidovudine, AZT, RT HO N O CAS#30516-87-1 O inhibitor, chain terminator, 3’-Azido-3-deoxythymidine N RdRp inhibitor 3 O HO GL102922 NH HO N O CAS#111495-90-0 O Anti-HIV agent 3’-Azido-2’,3’-dideoxy-5-hydroxyuridine N3 O GL100679; CAS#73971-82-1 NH 1-(3-beta-Azido-2,3-dideoxy-beta-D-threo HO N O HIV-1 replication inhibitor O pentafuranosyl)thymine N3 GL101976 O HN HIV drug Stavudine, RT, RdDp CAS#3056-17-5 HO O N O inhibitor 2’,3’-Dideoxy-2’,3’-didehydrothymidine, D4T GL101381 NH2 N CAS#7481-88-1 HO N O HIV-1 inhibitor, D4C O 2’,3’-Dideoxy-2’,3’-didehydro-cytidine, ddddC O GL101563 I NH 治疗单纯疱诊性病毒角膜炎 CAS#105784-83-6 HO N O O herpes simplex keratitis drug 5-Iodo-2’,3’-dideoxyuridine, IddU NH2 GL101391 F N CAS#134379-77-4; 2’,3’-Dideoxy-2’,3’- HO N O antiviral drug Dexelvucitabine didehydro-5-fluoro-cytidine O GL101382 NH2 N HIV drug Zalcitabine, RT/RdRp CAS#7481-89-2 HO N O O inhibitor 2’,3’-Dideoxycytidine, ddC NH2 GL101392 F N CAS#107036-62-4 HO N O HIV-1 inhibitor 2’,3’-Dideoxy-5-fluorocytidine, 5FddC O GL101975 O N NH HIV drug, didanosine, DDI, RT, CAS#69655-05-6 HO N N O RdDp inhibitor 2’,3’-dideoxyinosine GL102003 NH2 N CAS#4097-22-7 N antiviral drug, DDA HO N N O 2',3'-dideoxy adenosine Please contact Haoyun (Harry) An at [email protected] or Sherry Li at [email protected] or visit www.granlen.com for inquiries or additional questions 4 .

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    4 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us